Published in Am J Dig Dis on August 01, 1974
The life and times of the Enterococcus. Clin Microbiol Rev (1990) 16.58
Problems of bacterial infection in patients with liver disease. Gut (1987) 1.47
Spontaneous bacterial peritonitis due to a group IIk-2 strain. J Clin Microbiol (1980) 1.30
Antibiotic penetrance of ascitic fluid in dogs. Antimicrob Agents Chemother (1976) 0.98
Fatal Pasteurella dagmatis peritonitis and septicaemia in a patient with cirrhosis: a case report and review of the literature. J Clin Pathol (2004) 0.94
Spontaneous bacterial peritonitis. Gut (1985) 0.89
Nontypeable Haemophilus influenzae as a cause of spontaneous bacterial peritonitis. J Clin Microbiol (2006) 0.87
Ascitic fluid pH in alcoholic cirrhosis: a reevaluation of its use in the diagnosis of spontaneous bacterial peritonitis. Gut (1985) 0.80
Spontaneous bacterial peritonitis: Analysis of treatment and outcome. Can J Infect Dis (1991) 0.79
Radioimmunoassay and opsonic antibody responses to pneumococcal capsular polysaccharide vaccine in serum and ascitic fluid of cirrhotic patients. J Clin Microbiol (1983) 0.76
Citrate in oral rehydration therapy. Gut (1985) 0.75
Spontaneous peritonitis caused by Enterococcus faecium. J Clin Microbiol (1990) 0.75
The absolute granulocyte count in ascites fluid. An aid to the diagnosis of spontaneous bacterial peritonitis. West J Med (1977) 0.75
Editorial: Diagnostic ascitic tap in cirrhosis. Br Med J (1975) 0.75
Peritoneal fluid concentrations of gentamicin in patients with spontaneous bacterial peritonitis. Antimicrob Agents Chemother (1981) 0.75
Infections caused by group F streptococci. Can Med Assoc J (1981) 0.75
Infectious disease emergencies. Part IV: Patients presenting with gastrointestinal disorders. West J Med (1977) 0.75
Healing of duodenal ulcer with an antacid regimen. N Engl J Med (1977) 3.32
Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol (2000) 3.08
Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology (1990) 3.04
The physiology and pathophysiology of gastric emptying in humans. Gastroenterology (1984) 2.93
Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci (1998) 2.84
Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil (2006) 2.61
Cyclic vomiting syndrome in adults. Neurogastroenterol Motil (2008) 2.40
Gastric distention: a mechanism for postprandial gastroesophageal reflux. Gastroenterology (1985) 2.37
Clinical approaches to irritable bowel syndrome. Lancet (1992) 2.28
Gastric emptying in patients with gastroesophageal reflux. Gastroenterology (1981) 2.02
Topical aspirin plus HCl gastric lesions in the rat. Cytoprotective effect of prostaglandin, cimetidine, and probanthine. Gastroenterology (1979) 1.97
Afferent nerve-mediated protection against deep mucosal damage in the rat stomach. Gastroenterology (1990) 1.94
Diagnosis and treatment of chronic intestinal pseudo-obstruction in children: report of consensus workshop. J Pediatr Gastroenterol Nutr (1997) 1.79
Characteristics and frequency of transient relaxations of the lower esophageal sphincter in patients with reflux esophagitis. Gastroenterology (1988) 1.77
Impact of acid and pepsin on human esophageal prostaglandins. Am J Gastroenterol (1994) 1.75
Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth, and agar dilution methods and their clinical relevance. J Clin Microbiol (1993) 1.70
Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther (2007) 1.65
Identification and mechanism of delayed esophageal acid clearance in subjects with hiatus hernia. Gastroenterology (1987) 1.64
Abnormal gastric myoelectrical activity and delayed gastric emptying in patients with symptoms suggestive of gastroparesis. Dig Dis Sci (1996) 1.62
Randomised clinical trial: ghrelin agonist TZP-101 relieves gastroparesis associated with severe nausea and vomiting--randomised clinical study subset data. Aliment Pharmacol Ther (2011) 1.62
Enhancement of salivary esophagoprotection: rationale for a physiological approach to gastroesophageal reflux disease. Gastroenterology (1996) 1.57
The hypertensive lower esophageal sphincter. Manometric and clinical aspects. Dig Dis Sci (1989) 1.54
Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost (2012) 1.51
Viral gastroparesis: a subgroup of idiopathic gastroparesis--clinical characteristics and long-term outcomes. Am J Gastroenterol (1997) 1.51
The role of prolonged esophageal pH monitoring in the diagnosis of gastroesophageal reflux. JAMA (1984) 1.49
Metoclopramide: pharmacology and clinical application. Ann Intern Med (1983) 1.49
Hepatitis C infection by polymerase chain reaction in alcoholics: false-positive ELISA results and the influence of infection on a clinical prognostic score. Am J Gastroenterol (1993) 1.48
Laparotomy stimulates an endogenous gastric mucosal protective mechanism in the rat. A microcirculatory and morphologic study of ethanol injury. Gastroenterology (1988) 1.47
Histologic and microcirculatory changes in alcohol-induced gastric lesions in the rat: effect of prostaglandin cytoprotection. Gastroenterology (1984) 1.46
Characteristics of transient lower esophageal sphincter relaxation in humans. Am J Physiol (1987) 1.46
Monophasic luminal release of prostaglandin E2 in patients with reflux esophagitis under the impact of acid and acid/pepsin solutions. Its potential pathogenetic significance. J Clin Gastroenterol (1995) 1.45
Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis. Endoscopy (1997) 1.44
Effects of pacing parameters on entrainment of gastric slow waves in patients with gastroparesis. Am J Physiol (1998) 1.43
A 20-minute breath test for helicobacter pylori. Am J Gastroenterol (1991) 1.43
Superiority of the flexible to the rigid sigmoidoscope in routine proctosigmoidoscopy. N Engl J Med (1980) 1.40
Exogenous prostaglandin protects against acid-induced deep mucosal injury by stimulating alkaline secretion in rat duodenum. Dig Dis Sci (1989) 1.39
The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am J Gastroenterol (1993) 1.38
Role of oxygen-derived free radicals in hemorrhagic shock-induced gastric lesions in the rat. Gastroenterology (1985) 1.38
Role of bacteria in gastric ulceration produced by indomethacin in the rat: cytoprotective action of antibiotics. Gastroenterology (1983) 1.36
Serosal and cutaneous recordings of gastric myoelectrical activity in patients with gastroparesis. Am J Physiol (1994) 1.36
Modulation of feline esophageal contractions by bolus volume and outflow obstruction. Am J Physiol (1990) 1.34
Gastric pacing is a new surgical treatment for gastroparesis. Am J Surg (2001) 1.33
Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil (2009) 1.32
Sensory neurons mediate protective vasodilatation in rat gastric mucosa. Am J Physiol (1991) 1.31
Sensory neurons signal for an increase in rat gastric mucosal blood flow in the face of pending acid injury. Gastroenterology (1991) 1.29
Erythromycin: a motilin agonist and gastrointestinal prokinetic agent. Am J Gastroenterol (1993) 1.29
Wireless pH-motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation. Neurogastroenterol Motil (2010) 1.29
Gastric myoelectrical activity and gastric emptying in patients with functional dyspepsia. Am J Gastroenterol (1999) 1.27
Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial. Adv Med Sci (2007) 1.26
Clinical-histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium. Neurogastroenterol Motil (2012) 1.25
The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology. Aliment Pharmacol Ther (2009) 1.25
Electrical and mechanical activity in the human lower esophageal sphincter during diaphragmatic contraction. J Clin Invest (1988) 1.22
Association of the status of interstitial cells of Cajal and electrogastrogram parameters, gastric emptying and symptoms in patients with gastroparesis. Neurogastroenterol Motil (2009) 1.21
Interaction of levodopa and metoclopramide on gastric emptying. Clin Pharmacol Ther (1980) 1.20
Scintigraphic determination of small intestinal transit time: comparison with the hydrogen breath technique. Gastroenterology (1984) 1.19
Contribution of no-reflow phenomenon to hepatic injury after ischemia-reperfusion: evidence for a role for superoxide anion. Hepatology (1992) 1.19
Metoclopramide stimulates prolactin secretion in man. J Clin Endocrinol Metab (1976) 1.18
Clinical applications of electrogastrography. Am J Gastroenterol (1993) 1.17
Gastric vasoconstrictor actions of leukotriene C4, PGF2 alpha, and thromboxane mimetic U-46619 on rat submucosal microcirculation in vivo. Am J Physiol (1985) 1.17
Radionuclide esophageal emptying of a solid meal to quantitate results of therapy in achalasia. Gastroenterology (1983) 1.17
Cisapride: a new class of prokinetic agent. The ACG Committee on FDA-related matters. American College of Gastroenterology. Am J Gastroenterol (1991) 1.14
Review article: cyclic vomiting syndrome in adults--rediscovering and redefining an old entity. Aliment Pharmacol Ther (2011) 1.13
Gastric slow wave abnormalities in patients with gastroparesis. Am J Gastroenterol (1992) 1.13
Microvascular actions of platelet-activating factor on rat gastric mucosa and submucosa. Am J Physiol (1986) 1.13
Human lower esophageal sphincter pressure response to increased intra-abdominal pressure. Am J Physiol (1990) 1.13
Microcirculatory and mast cell changes in restraint-induced gastric ulcer. Gastroenterology (1966) 1.13
Immunochemical and serological studies of enzymatically fractionated human IgG globulins. I. Hydrolysis with pepsin, papain, ficin and bromelin. Immunochemistry (1968) 1.12
Clostridial gas gangrene. I. Cellular and molecular mechanisms of microvascular dysfunction induced by exotoxins of Clostridium perfringens. J Infect Dis (2000) 1.12
Artifact reduction in electrogastrogram based on empirical mode decomposition method. Med Biol Eng Comput (2000) 1.12
Acceleration of gastric emptying with electrical stimulation in a canine model of gastroparesis. Am J Physiol (1992) 1.12
Motility of the antroduodenum in healthy and gastroparetics characterized by wireless motility capsule. Neurogastroenterol Motil (2010) 1.12
Effect of aspirin plus hydrochloric acid on the gastric mucosal microcirculation. Gastroenterology (1987) 1.10
Median arcuate ligament syndrome: a possible cause of idiopathic gastroparesis. Am J Gastroenterol (1997) 1.10
Computerized curve fitting in the analysis of hydrogen gas clearance curves. Am J Physiol (1989) 1.10
Effects of metoclopramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients. Gastroenterology (1983) 1.10
Electrogastrography: measurement, analysis and prospective applications. Med Biol Eng Comput (1991) 1.09
Regional gastric mucosal blood flow measurements by hydrogen gas clearance in the anesthetized rat and rabbit. Gastroenterology (1984) 1.09
Role of food in gastrointestinal ulceration produced by indomethacin in the rat. Gastroenterology (1982) 1.08
In vivo microscopy of the gastric microcirculation. Am J Dig Dis (1972) 1.08
The clinical value of ascitic fluid culture and leukocyte count studies in alcoholic cirrhosis. Gastroenterology (1976) 1.08
Human esophageal secretion: mucosal response to luminal acid and pepsin. Gastroenterology (1994) 1.07
Cellular bicarbonate protects rat duodenal mucosa from acid-induced injury. J Clin Invest (2001) 1.07
Do bile acids reflux into the esophagus? A study in normal subjects and patients with gastroesophageal reflux disease. Gastroenterology (1987) 1.07
Clostridial gas gangrene. II. Phospholipase C-induced activation of platelet gpIIbIIIa mediates vascular occlusion and myonecrosis in Clostridium perfringens gas gangrene. J Infect Dis (2000) 1.07
Neuropeptide control of rat gastric mucosal blood flow. Increase by calcitonin gene-related peptide and vasoactive intestinal polypeptide, but not substance P and neurokinin A. Circ Res (1991) 1.06
Effect of prostaglandin E2 on aspirin induced lysosomal membrane labilization. Proc West Pharmacol Soc (1982) 1.06
Effects of nifedipine on esophageal motor function in humans: correlation with plasma nifedipine concentration. Gastroenterology (1984) 1.05
Clinical significance of gastric myoelectrical dysrhythmias. Dig Dis (1996) 1.05
Ultrastructure of another spiral organism associated with human gastritis. Dig Dis Sci (1989) 1.05
Barrier function of the gastric mucus gel. Am J Physiol (1995) 1.05
Efficiency and efficacy of multi-channel gastric electrical stimulation. Neurogastroenterol Motil (2005) 1.05
Tonic dopaminergic suppression of plasma aldosterone. J Clin Endocrinol Metab (1980) 1.05
Definition of a gastric emptying abnormality in patients with anorexia nervosa. Dig Dis Sci (1985) 1.04
Esophageal disease in patients with angina-like chest pain. Am J Gastroenterol (1981) 1.04
Human spasmolytic polypeptide decreases proton permeation through gastric mucus in vivo and in vitro. Am J Physiol (1997) 1.04
Protection by histamine receptor antagonists and prostaglandin against gastric mucosal barrier disruption in the rat. Gastroenterology (1979) 1.03
Gastroduodenal mucus gel thickness in patients with Helicobacter pylori: a method for assessment of biopsy specimens. Am J Gastroenterol (1991) 1.03
Acid-sensing pathways of rat duodenum. Am J Physiol (1999) 1.03